NextCell Pharma Gross Profit vs. Net Income
Based on the key profitability measurements obtained from NextCell Pharma's financial statements, NextCell Pharma AB may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in January. Profitability indicators assess NextCell Pharma's ability to earn profits and add value for shareholders.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
Please note, there is a significant difference between NextCell Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if NextCell Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NextCell Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
For NextCell Pharma profitability analysis, we use financial ratios and fundamental drivers that measure the ability of NextCell Pharma to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well NextCell Pharma AB utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between NextCell Pharma's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of NextCell Pharma AB over time as well as its relative position and ranking within its peers.
NextCell |
NextCell Pharma AB Net Income vs. Gross Profit Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining NextCell Pharma's current stock value. Our valuation model uses many indicators to compare NextCell Pharma value to that of its competitors to determine the firm's financial worth. NextCell Pharma AB is considered to be number one stock in gross profit category among its peers. It also is considered to be number one stock in net income category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the NextCell Pharma's earnings, one of the primary drivers of an investment's value.NextCell Net Income vs. Gross Profit
Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
NextCell Pharma |
| = | (2.49 M) |
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
NextCell Pharma |
| = | (35.02 M) |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
NextCell Net Income Comparison
NextCell Pharma is currently under evaluation in net income category among its peers.
NextCell Pharma Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in NextCell Pharma, profitability is also one of the essential criteria for including it into their portfolios because, without profit, NextCell Pharma will eventually generate negative long term returns. The profitability progress is the general direction of NextCell Pharma's change in net profit over the period of time. It can combine multiple indicators of NextCell Pharma, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
NextCell Pharma AB operates as a tissue establishment and primary biobank in Sweden. NextCell Pharma AB was founded in 2014 and is based in Huddinge, Sweden. NextCell Pharma operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. It employs 10 people.
NextCell Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on NextCell Pharma. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of NextCell Pharma position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the NextCell Pharma's important profitability drivers and their relationship over time.
Learn to be your own money manager
Our tools can tell you how much better you can do entering a position in NextCell Pharma without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Competition Analyzer Now
Competition AnalyzerAnalyze and compare many basic indicators for a group of related or unrelated entities |
| All Next | Launch Module |
Use Investing Themes to Complement your NextCell Pharma position
In addition to having NextCell Pharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Pharmaceutical Products Thematic Idea Now
Pharmaceutical Products
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Pharmaceutical Products theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Pharmaceutical Products Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for NextCell Stock Analysis
When running NextCell Pharma's price analysis, check to measure NextCell Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NextCell Pharma is operating at the current time. Most of NextCell Pharma's value examination focuses on studying past and present price action to predict the probability of NextCell Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NextCell Pharma's price. Additionally, you may evaluate how the addition of NextCell Pharma to your portfolios can decrease your overall portfolio volatility.